Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Psilocybin Enhanced Group Psychotherapy in Patients with Cancer, HOPE Study

Trial Status: complete

This early phase I trial studies side effects and feasibility of giving psilocybin in a group setting in patients with cancer. Psilocybin is a natural product produced by numerous species of Psilocybe mushrooms. It is known as a hallucinogen and it has potential for creating positive behavior changes in a variety of psychiatric conditions. This study aims to see whether psilocybin is safe to be part of group therapy.